The 1998 Tour de France was a bust. Seven people—one rider and six support crew—were suspected of using or providing riders with a synthetic version of erythropoietin (EPO), a hormone that stimulates production of red blood cells. The authorities couldn’t confirm the suspicions, however, since no test could distinguish synthetic EPO from natural EPO in blood or urine.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.